Centessa Pharmaceuticals plc - American Depositary Shares (CNTA)

Investors were optimistic about the company potentially reaping $250 million in gross proceeds from an equity offering.

As the digital age continues its relentless march, a new contender has emerged for the title of the world's most valuable commodity: neural data. Far surpassing traditional resources like oil or even conventional personal data, information gleaned directly from the human nervous system is rapidly becoming the "black gold" of

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

CNTA stock shows strong technical momentum and a high-quality consolidation pattern, signaling a potential breakout for traders.

A handful of biotech stocks are showing renewed strength, with big spikes in their Benzinga Edge Ranking's Momentum scores.

All four companies are testing out orexin agonists to improve the symptoms of narcolpesy.

Centessa Pharmaceuticals revealed promising interim Phase 1 trial results for ORX750, demonstrating significant improvements in sleep latency for acutely sleep-deprived healthy volunteers. The company plans to advance ORX750 into Phase 2 studies targeting narcolepsy and idiopathic hypersomnia in Q4 2024.

The company tested a potential narcolepsy treatment in healthy, but sleep-deprived, volunteers.

CNTA stock results show that Centessa Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.

CNTA stock results show that Centessa Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.

CNTA stock results show that Centessa Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.

With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply during Friday’s session following upbeat results.

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.

U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session.